Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.85 -0.04 (-1.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Accumulated Depreciation (2019 - 2022)

Updated

Kalaris Therapeutics' Accumulated Depreciation was $1 million in Q4 2022, up 257.3% from $281,000 a year earlier.

Analysis

Kalaris Therapeutics (KLRS) Accumulated Depreciation (2019 - 2022) Analysis & Trends

From Q4 2019 onward, Kalaris Therapeutics has reported Accumulated Depreciation for 4 quarters.

  • Accumulated Depreciation has now increased for three consecutive years, with a three-year compound annual growth rate of 275.3% (FY2019 to FY2022).
  • In earlier years, Accumulated Depreciation was $281,000 in FY2021 (+205.4%), $92,000 in FY2020 (+384.2%) and $19,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kalaris Therapeutics 68.80 Mn 68.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.00 Mn
Dec 31, 2021 281,000.00
Dec 31, 2020 92,000.00
Dec 31, 2019 19,000.00
API Access

Kalaris Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=KLRS&period=max&api_key=YOUR_API_KEY